As of 2025-04-29, the Relative Valuation of Integragen SA (ALINT.PA) is (1.05) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.54 EUR, the upside of Integragen SA based on Relative Valuation is -294.3%.
The range of the Relative Valuation is (0.98) - (1.12) EUR.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 10.0x - 11.4x | 10.7x |
| Fair Price | (0.98) - (1.12) | (1.05) |
| Upside | -282.0% - -306.7% | -294.3% |
| Date | P/E |